IP Library Granted Patent US 7,994,351
Granted Patent B2
US 7,994,351 · App. 12/613,969 · Granted Aug 9, 2011

Preparation of bile acids and intermediates thereof

Assignee: Kythera Biopharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,994,351
App. No.
12/613,969
Granted
Aug 9, 2011
Kind
B2
Abstract

Synthetic methods for preparing deoxycholic acid and intermediates thereof are provided.

Claims (36)

1. A compound selected from the group consisting of

9α-hydroxy-5β-androstan-3,17-dione (1.1);

5β-androst-9(11)-en-3,17-dione (1.2);

(Z)-3α-hydroxy-5β-pregna-9(11),17(20)-diene (1.5);

(Z)-3α-acetoxy-5β-pregna-9(11),17(20)-diene (1.6);

(E)-methyl 3α-acetoxy-5β-chol-9(11), 16, 22-trien-24-oate (1.7a); and

methyl 3α-acetoxy-5β-chol-9(11), 16-dien-24-oate (1.7b).

2. The compound of claim 1 , which is 9α-hydroxy-5β-androstan-3,17-dione (1.1).

3. The compound of claim 1 , which is 5β-androst-9(11)-en-3,17-dione (1.2).

4. The compound of claim 1 , which is (Z)-3α-hydroxy-5β-pregna-9(11),17(20)-diene (1.5).

5. The compound of claim 1 , which is (Z)-3α-acetoxy-5β-pregna-9(11),17(20)-diene (1.6).

6. The compound of claim 1 , which is (E)-methyl 3α-acetoxy-5β-chol-9(11), 16,22-trien-24-oate (1.7a).

7. The compound of claim 1 , which is methyl 3α-acetoxy-5β-chol-9(11), 16-dien-24-oate (1.7b).

8. A method of preparing a compound of formula 1.9:

said method comprising:

(a) reacting 9α-hydroxyandrost-4-en-3,17-dione 1.0 with H 2 under hydrogenation conditions to form compound 1.1

(b) reacting compound 1.1 with acid to form compound 1.2

(c) reacting compound 1.2 with a reducing agent to form compound 1.3 or a mixture of 1.3 and 1.4

(d) reacting compound 1.3 with a two carbon olefination reagent under olefin forming conditions to form compound 1.5

(e) converting compound 1.5 to a compound of formula 1.6 wherein P is a protecting group

(f) reacting the compound of formula 1.6 with an alkylpropiolate of the formula CH≡CC(O)OR or an alkyl acrylate of the formula CH 2 ═CHC(O)OR, wherein R is alkyl, in the presence of a Lewis acid to form a compound of formula 1.7 wherein P is a protecting group, R is an alkyl, and the dashed line is a single or double bond;

(g) reacting the compound of formula 1.7 with H 2 under hydrogenation conditions to form a compound of formula 1.8 wherein P is a protecting group and R is alkyl

(h) reacting the compound of formula 1.8 with an oxidizing agent to form the compound of formula 1.9 wherein P is a protecting group and R is alkyl.

9. A method for preparing deoxycholic acid (DCA) or a pharmaceutically acceptable salt thereof:

said method comprising

(a) reacting 9α-hydroxyandrost-4-en-3,17-dione 1.0 with H 2 under hydrogenation conditions comprising a Pd/C catalyst to form compound 1.1

(b) reacting compound 1.1 with H 2 SO 4 to form compound 1.2

(c) reacting compound 1.2 with LiAl(OtBu) 3 H to form compound 1.3 or a mixture of 1.3 and 1.4

(d) reacting compound 1.3 with Ph 3 PCH 2 CH 3 + Br under olefin forming conditions to form compound 1.5

(e) converting compound 1.5 to a compound of formula 1.6

(f) reacting the compound of formula 1.6 with methylpropiolate of the formula CH≡CC(O)OCH 3 or methyl acrylate of the formula CH 2 ═CHC(O)OCH 3 , in the presence of EtAlCl 2 to form a compound of formula 1.7 wherein, and the dashed line is a single or double bond;

(g) reacting the compound of formula 1.7 with H 2 under hydrogenation conditions comprising a PtO 2 catalyst to form a compound of formula 1.8

(h) reacting the compound of formula 1.8 with CrO 3 to form a compound of formula 1.9

(i) reacting the compound of formula 1.9 with H 2 under hydrogenation conditions comprising a Pd/C catalyst to form a compound of formula 2.0

(j) reacting the compound of formula 2.0 with LiAl(OtBu) 3 H to form a compound of formula 2.1

(k) exposing the compound of formula 2.1 to deprotection and hydrolysis conditions comprising LiOH to form deoxycholic acid or a pharmaceutically acceptable salt thereof.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Oct 25, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 050834/0240 →
CHANGE OF NAME Recorded Oct 8, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 050672/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2010
From: PRASAD, ACHAMPETA RATHAN; SWARINGEN, ROY A., JR.; REID, JOHN GREGORY; MORIARTY, ROBERT M.; SAHOO, AKHILA KUMAR
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 024627/0351 →
Priority Claims (1)
GB 0807615.0 · Apr 25, 2008 · national
Continuity (2)
Continuation 12153446 · May 16, 2008
Related Publication 20100145083A1 · Jun 10, 2010